Long‐term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention‐deficit/hyperactivity disorder

AIMS: As an extension of a phase 2/3 study evaluating the efficacy and safety of lisdexamfetamine dimesylate (LDX) 30, 50, or 70 mg/d for 4 weeks in Japanese patients aged 6‐17 years with attention‐deficit/hyperactivity disorder (ADHD), this study evaluated its long‐term safety and efficacy. METHODS...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuropsychopharmacol Rep
Main Authors: Ichikawa, Hironobu, Miyajima, Tasuku, Yamashita, Yushiro, Fujiwara, Masakazu, Fukushi, Akimasa, Saito, Kazuhiko
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7292222/
https://ncbi.nlm.nih.gov/pubmed/31814294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/npr2.12091
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker